Hinge Health (NYSE:HNGE) Now Covered by Raymond James

Raymond James started coverage on shares of Hinge Health (NYSE:HNGE) in a report issued on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $45.00 target price on the stock.

Several other equities analysts have also issued reports on HNGE. Canaccord Genuity Group started coverage on shares of Hinge Health in a report on Monday. They issued a “buy” rating and a $52.00 price target on the stock. Morgan Stanley assumed coverage on shares of Hinge Health in a research report on Monday. They set an “overweight” rating and a $46.00 target price for the company. Wall Street Zen upgraded shares of Hinge Health to a “hold” rating in a research report on Monday, June 2nd. Needham & Company LLC began coverage on Hinge Health in a research report on Monday. They set a “buy” rating and a $47.00 price target for the company. Finally, Evercore ISI initiated coverage on shares of Hinge Health in a report on Monday. They issued an “outperform” rating and a $50.00 price objective for the company. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, Hinge Health has a consensus rating of “Moderate Buy” and a consensus target price of $46.00.

Hinge Health Price Performance

Shares of NYSE:HNGE opened at $36.65 on Monday. Hinge Health has a 52 week low of $33.42 and a 52 week high of $43.80.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.